Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

  title={Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies},
  author={Mike A. Nalls and Cornelis Blauwendraat and Costanza Ludovica Vallerga and Karl Heilbron and Sara Bandres-Ciga and Diana Chang and Manuela M X Tan and Demis A. Kia and Alastair J. Noyce and Angli Xue and Jose Bras and Emily Young and Rainer von Coelln and Javier Sim{\'o}n‐S{\'a}nchez and Claudia Schulte and Manu Sharma and Lynne Krohn and Lasse Pihlstr{\o}m and Ari Siitonen and Hirotaka Iwaki and Hampton L. Leonard and Faraz Faghri and J. Raphael Gibbs and Dena G Hernandez and Sonja W. Scholz and Juan A. Bot{\'i}a and Maria Martinez and Jean‐Christophe Corvol and Suzanne Lesage and Joseph Jankovic and Lisa M. Shulman and Margaret Sutherland and Pentti J. Tienari and Kari Majamaa and Mathias Toft and Ole Andreas Andreassen and Tushar Bangale and Alexis Brice and Jian Yang and Ziv Gan‐Or and Thomas Gasser and Peter Heutink and Joshua M. Shulman and Nicholas W. Wood and David A. Hinds and John Hardy and Huw R. Morris and Jacob Gratten and Peter M. Visscher and Robert R. Graham and Andrew B. Singleton and Astrid D. Adarmes-G{\'o}mez and Miquel Aguilar and Akbota Aitkulova and Vadim Akhmetzhanov and Roy N. Alcalay and Ignacio {\'A}lvarez and Victoria {\'A}lvarez and Francisco J Barrero and Jes{\'u}s Alberto Bergareche Yarza and Inmaculada Bernal-Bernal and Kimberley J. Billingsley and Marta Bl{\'a}zquez and Marta Bonilla-Toribio and Juan A. Bot{\'i}a and Mar{\'i}a Teresa Boungiorno and Kathrin Brockmann and Vivien J. Bubb and Dolores Buiza‐Rueda and Ana C{\'a}mara and F{\'a}tima Carrillo and Mario Carri{\'o}n-Claro and D{\'e}bora Mar{\'i}a Cerd{\'a}n and Viorica Chelban and Jordi Clarim{\'o}n and Carl E. Clarke and Yaroslau Compta and Mark R. Cookson and David Wesley Craig and Fabrice Danjou and M{\'o}nica Diez-Fairen and Oriol Dols-Icardo and Jacinto Duarte and Raquel Dur{\'a}n and Francisco Escamilla-Sevilla and Valentina Escott-Price and Mario Ezquerra and Cici Feliz and Manel Fern{\'a}ndez and Rub{\'e}n Fern{\'a}ndez-Santiago and Steven Finkbeiner and Thomas Foltynie and Ciara Garc{\'i}a and Pedro J Garcia-Ruiz and Maria Jose G{\'o}mez Heredia and Pilar G{\'o}mez-Garre and Manuel Men{\'e}ndez Gonz{\'a}lez and Isabel Gonz{\'a}lez-Aramburu and Sebastian Guelfi and Rita Guerreiro and John Hardy and Sharon Hassin-Baer and Janet Hoenicka and Peter A. Holmans and Henry Houlden and Jon Infante and Silvia Jes{\'u}s and Adriano Jim{\'e}nez-Escrig and Gulnaz Kaishybayeva and Rauan Kaiyrzhanov and Altynay Karimova and Kerri J. Kinghorn and Sulev K{\~o}ks and Jaime Kulisevsky and Miguel A. Labrador-Espinosa and Hampton L. Leonard and Patrick A. Lewis and Jos{\'e} Luis L{\'o}pez-Send{\'o}n and Ruth C. Lovering and Steven J. Lubbe and Codrin Lungu and Daniel Macias and Claudia Manzoni and Juan Mar{\'i}n and Johan Marinus and Maria Jose Marti and Irene Mart{\'i}nez Torres and Juan Carlos Mart{\'i}nez‐Castrillo and Marina Mata and Niccol{\`o} Emanuele Mencacci and Carlota M{\'e}ndez-del-Barrio and Ben Middlehurst and Adolfo M{\'i}nguez and Pablo Mir and Kin Ying Mok and Esteban Mu{\~n}oz and Derek P. Narendra and Oluwadamilola O. Ojo and Njideka U. Okubadejo and Ana Gorostidi Pagola and Pau P{\'a}stor and Francisco P{\'e}rez Errazquin and Teresa Peri{\~n}{\'a}n-Tocino and Lasse Pihlstr{\o}m and H{\'e}l{\`e}ne Plun-Favreau and John Quinn and L{\'e}a R'bibo and Xylena Reed and Elisabet Mondragon Rezola and Mie Rizig and Patrizia Rizzu and Laurie A. Robak and Antonio Sanchez Rodriguez and Guy A. Rouleau and Javier Ruiz‐Martinez and Clara Ruz and Mina Ryten and Dinara Sadykova and Sebastian R. Schreglmann and Chingiz Shashkin and Mar{\'i}a Sierra and Esther Su{\'a}rez-Sanmartin and Pille Taba and C{\'e}sar Tabernero and Manuela X Tan and Juan Pablo Tartari and Cristina Tejera-Parrado and Eduardo Tolosa and Daniah Trabzuni and Francesc Valldeoriola and Jacobus J. van Hilten and Kendall Van Keuren-Jensen and Laura Vargas-Gonz{\'a}lez and Lydia Vela and Francisco Vives and Nigel Williams and Nazira Zharkinbekova and Zharkyn Zharmukhanov and Elena V. Zholdybayeva and Alexander Zimprich and Pauli Ylikotila and Lisa M. Shulman and Stephen G Reich and Joseph M. Savitt and Michelle Agee and Babak Alipanahi and Adam Auton and Robert K. Bell and Katarzyna Bryc and Sarah L Elson and Pierre Fontanillas and Nicholas A. Furlotte and Karen E. Huber and Barry Hicks and Ethan M. Jewett and Yunxuan Jiang and Aaron Kleinman and Keng-Han Lin and Nadia K. Litterman and Jennifer C McCreight and Matthew H. McIntyre and Kimberly F. McManus and Joanna L. Mountain and Elizabeth S. Noblin and Carrie A. M. Northover and Steven J. Pitts and G. David Poznik and Jarupon Fah Sathirapongsasuti and Janie F. Shelton and Suyash S. Shringarpure and Chao Tian and Joyce Y. Tung and Vladimir Vacic and Xin Wang and Catherine H. Wilson and Tim Anderson and Steven R Bentley and John C. Dalrymple-Alford and Javed Fowdar and Glenda M. Halliday and Anjali K. Henders and Ian B. Hickie and Irfahan Kassam and Martin Kennedy and John W Kwok and Simon J. G. Lewis and George D. Mellick and Grant Montgomery and John Pearson and Toni L. Pitcher and Julia Sidorenko and Peter Silburn and Costanza Ludovica Vallerga and Peter M. Visscher and Leanne Wallace and Naomi R. Wray and Futao Zhang},
  journal={The Lancet Neurology},

Figures from this paper

Large-scale Rare Variant Burden Testing in Parkinson's Disease Identifies Novel Associations with Genes Involved in Neuro-inflammation

This work investigated the rare genetic component of PD at minor allele frequencies <1%, using whole genome and whole exome sequencing data from 7,184 PD cases, 6,701 proxy-cases, and 51,650 healthy controls and identified several genes reaching exome-wide significance.

Genome-wide epistasis analysis in Parkinson's disease between populations with different genetic ancestry reveals significant variant-variant interactions

A genome-wide non-exhaustive epistasis screening pipeline called Variant-variant interaction through variable thresholds (VARI3) is developed and applied to diverse PD GWAS cohorts and identified several epistatic signals associated with PD and replicated associations despite differences in the genetic ancestry between cohorts.

Variable Effects of PD-Risk Associated SNPs and Variants in Parkinsonism-Associated Genes on Disease Phenotype in a Community-Based Cohort

The hypothesis that different gene and protein-protein interaction networks that underlie PD risk, the PD phenotype, and the neurodegenerative process leading to the disease phenotype are supported are supported and point to the significance of the genetic background on disease phenotype.

Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

The combination of all ALS-associated signals reveals a role for perturbations in vesicle-mediated transport and autophagy and provides evidence for cell-autonomous disease initiation in glutamatergic neurons.

Establishing gene regulatory networks from Parkinson’s disease risk loci

The results not only contribute to an overall understanding of the mechanisms and impact of specific combinations of PD-SNPs, but also highlight the potential impact gene regulatory networks may have when elucidating aetiological subtypes of PD.

Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease

This study refines the genetic architecture of Chr 4 underlying the AAO of the PD phenotype through the identification of BST1 as a novel AAO PD locus and opens a new direction for the development of treatments to delay the onset of PD.

The Parkinson’s Disease GWAS Locus Browser

This work has gathered data for all 2336 genes within 1Mb up and downstream of each variant to allow users to assess which gene(s) are most associated with the variant of interest based on a set of self-ranked criteria.

Fine-mapping of Parkinson’s disease susceptibility loci identifies putative causal variants

A robust list of likely causal variants underlying Parkinson’s Disease risk for further mechanistic studies is provided and the functional relevance of fine-mapped SNPs is confirmed using a suite of in silico validation approaches.

A transcriptome-wide association study identifies susceptibility genes for Parkinson’s disease

This work conducted a transcriptome-wide association study (TWAS) for PD using the summary statistics of over 480,000 individuals from the most recent PD GWAS to identify 18 genes significantly associated with PD after Bonferroni corrections and prioritized genes that are likely to affect PD by using a TWAS approach.



A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci

A key role for autophagy and lysosomal biology in PD risk is indicated, and potential new drug targets for PD are suggested.

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

A meta-analysis of Parkinson's disease genome-wide association studies using a common set of 7,893,274 variants found four loci, including GBA, GAK-DGKQ, SNCA and the HLA region, contain a secondary independent risk variant.

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk

A large genome-wide association study of clinically diagnosed AD and AD-by-proxy identifies new loci and functional pathways that contribute to AD risk and adds novel insights into the neurobiology of AD.

Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.

The results suggest that although GWASs are a useful tool in identifying the most common variants associated with complex disease, a great deal of common variants of small effect remain to be discovered.

Genome-wide association study of Parkinson’s disease progression biomarkers in 12 longitudinal patients’ cohorts

Novel genetic factors associated with heterogeneity of progression in Parkinson’s disease are identified and provide new insights into the pathogenesis of Parkinson's disease as well as patient stratification for clinical trials.

Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets

A method is proposed that integrates summary-level data from GWAS with data from expression quantitative trait locus (eQTL) studies to identify genes whose expression levels are associated with a complex trait because of pleiotropy, and prioritize 126 genes that provide important leads to design future functional studies.

Quantifying the mapping precision of genome-wide association studies using whole-genome sequencing data

The association signals at rare causal variants are very unlikely to be mapped to common variants in GWAS using either WGS data or imputed data and vice versa, suggesting WGS is an efficient strategy to detect and fine-map rare variants simultaneously.